Patents Assigned to Max-Planck-Gesellschaft zur Foerderung Der Wissenshaften e. V.
  • Graphene nanoribbon precursors and monomers suitable for preparation thereof
    Patent number: 9434619
    Abstract: Provided are graphene nanoribbon precursors comprising repeated units of the general formula (I) in which R1, R2 are each H, halogen, —OH, —NH2, —CN, —NO2 or a hydrocarbyl radical which has 1 to 40 carbon atoms and may be linear or branched, saturated or unsaturated and mono- or poly-substituted by halogen (F, Cl, Br, I), —OH, —NH2, —CN, and/or —NO2, where one or more CH2 groups may also be replaced by —O—, —S—, —C(O)O—, —O—C(O)—, —C(O)—, —NH— or —NR—, in which R is an optionally substituted C1C40-hydrocarbyl radical, or an optionally substituted aryl, alkylaryl or alkoxyaryl radical.
    Type: Grant
    Filed: October 24, 2012
    Date of Patent: September 6, 2016
    Assignees: BASF SE, Max-Planck-Gesellschaft zur Foerderung der Wissenshaften e.V.
    Inventors: Matthias Georg Schwab, Klaus Muellen, Xinliang Feng, Lukas Doessel
  • Tuberculosis vaccine with improved efficacy
    Patent number: 8545854
    Abstract: The present invention relates to novel recombinant vaccines providing protective immunity against tuberculosis. Further, the present invention refers to novel recombinant nucleic acid molecules, vectors containing said nucleic acid molecules, cells transformed with said nucleic acid molecules and polypeptides encoded by said nucleic acid molecules.
    Type: Grant
    Filed: June 22, 2011
    Date of Patent: October 1, 2013
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenshaften, e.V.
    Inventors: Leander Grode, Stefan H. E. Kaufmann, Baerbel Raupach, Juergen Hess
  • AGENT FOR IMPROVING TISSUE PENETRATION
    Publication number: 20120064147
    Abstract: The invention concerns a pharmaceutical preparation which improves penetration of active substances through the tissue membrane or barrier of the target organ.
    Type: Application
    Filed: April 19, 2011
    Publication date: March 15, 2012
    Applicants: Genzyme Corporation, Max-Planck Gesellschaft Zur Foerderung Der Wissenshaften E.V.
    Inventors: Hans-Jorg EIBL, Peter Hoffmann
  • Tuberculosis vaccine with improved efficacy
    Patent number: 7988980
    Abstract: The present invention relates to novel recombinant vaccines providing protective immunity against tuberculosis. Further, the present invention refers to novel recombinant nucleic acid molecules, vectors containing said nucleic acid molecules, cells transformed with said nucleic acid molecules and polypeptides encoded by said nucleic acid molecules.
    Type: Grant
    Filed: April 23, 2004
    Date of Patent: August 2, 2011
    Assignee: Max-Planck-Gesellschaft zur Foerderung Der Wissenshaften e. V.
    Inventors: Leander Grode, Stefan H. E. Kaufmann, Bärbel Raupach, Jürgen Hess
  • AGENT FOR IMPROVING TISSUE PENETRATION
    Publication number: 20090312440
    Abstract: The invention concerns a pharmaceutical preparation which improves penetration of active substances through the tissue membrane or barrier of the target organ.
    Type: Application
    Filed: January 21, 2009
    Publication date: December 17, 2009
    Applicants: Max-Planck-Gesellschaft Zur Foerderung Der Wissenshaften E.V., Genzyme Corporation
    Inventors: Hansjorg EIBL, Peter Hoffman
  • PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS
    Publication number: 20080214849
    Abstract: The invention relates to phospholipid-like compounds having defined apolar constituents and to the use of such compounds as liposomes, active ingredients, and solubilizers.
    Type: Application
    Filed: August 29, 2007
    Publication date: September 4, 2008
    Applicant: Max-Planck-Gesellschaft Zur Foerderung Der Wissenshaften E.V.
    Inventors: Eibl Hansjorg, Thomas Hottkowitz
  • Agent for improving tissue penetration
    Publication number: 20080003277
    Abstract: The invention concerns a pharmaceutical preparation which improves penetration of active substances through the tissue membrane or barrier of the target organ.
    Type: Application
    Filed: March 12, 2007
    Publication date: January 3, 2008
    Applicants: Max-Planck-Gesellschaft Zur Foerderung Der Wissenshaften E.V., Genzyme Corporation
    Inventors: Hansjorg Eibl, Peter Hoffmann
  • Method and device for creating a two-dimensional representation of a three-dimensional structure
    Patent number: 7289118
    Abstract: The invention relates to a method and a device for two-dimensionally representing a three-dimensional world, in which rays are combined into packets during ray tracing, and said packets of rays are processed in adequate steps.
    Type: Grant
    Filed: August 20, 2003
    Date of Patent: October 30, 2007
    Assignees: Universität des Saarlandes, Max-Planck-Gesellschaft zur Förderung der Wissenshaften e.V.
    Inventors: Jörg Schmittler, Ingo Wald, Philipp Slusallek